Clinical Trial Update: Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops [NA]

View source ↗

Summary

This update reports the withdrawal of a clinical trial evaluating rizatriptan for acute attacks of chronic post-traumatic headache in U.S. military personnel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Headache

Drugs mentioned

• Rizatriptan (Rizatriptan)

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: Chronic Post-traumatic Headache | NA | Status: WITHDRAWN